Preventive effect of crocin on osteoporosis in an ovariectomized rat model

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Cao, Peng Chong ^a   Xiao, Wen Xing ^b   Yan, Ya Bo ^a   Zhao, Xiong ^a   Liu, Shuai ^a   Feng, Jing ^a   Zhang, Wei ^a   Wang, Jun ^a   Feng, Ya Fei ^a   Lei, Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Baoji Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CROCIN; ESTRADIOL; MANGANESE SUPEROXIDE DISMUTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE TISSUE; BONE TURNOVER; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ESTROGEN DEFICIENCY; FEMALE; FEMUR; LUMBAR VERTEBRA; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOLYSIS; OVARIECTOMY-INDUCED OSTEOPOROSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SERUM; THERAPY EFFECT; THREE DIMENSIONAL IMAGING; TRABECULAR BONE; TREATMENT DURATION; URINE; UTERUS; UTERUS WEIGHT; WESTERN BLOTTING;

EID: 84907228647     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/825181     Document Type: Article

References (62)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, Therapy, Osteoporosis prevention, diagnosis, and therapy. The Journal of the American Medical Association 2001 285 6 785 795
2. Eastell R., Black D. M., Boonen S., Adami S., Felsenberg D., Lippuner K., Cummings S. R., Delmas P. D., Palermo L., Mesenbrink P., Cauley J. A., Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. The Journal of Clinical Endocrinology & Metabolism 2009 94 9 3215 3225 10.1210/jc.2008-2765 2-s2.0-69949111096
3. Burge R., Dawson-Hughes B., Solomon D. H., Wong J. B., King A., Tosteson A., Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. Journal of Bone and Mineral Research 2007 22 3 465 475 10.1359/jbmr.061113 2-s2.0-34247194211
4. Omsland T. K., Emaus N., Tell G. S., Mortality following the first hip fracture in Norwegian women and men (1999-2008). A NOREPOS study. Bone 2014 63 81 86 10.1016/j.bone.2014.02.016
5. Marcus R., An expanded overview of postmenopausal osteoporosis. Journal of Musculoskeletal Neuronal Interactions 2002 2 3 195 197 2-s2.0-0036119320
6. Sugerman D. T., JAMA patient page. Osteoporosis. JAMA 2014 311 1, article 104
7. Johnell O., Kanis J. A., An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International 2006 17 12 1726 1733 10.1007/s00198-006-0172-4 2-s2.0-33750209491
8. Stevenson J. C., Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 2005 51 2 113 126 10.1016/j.maturitas.2005.01.012 2-s2.0-19444384640
9. Prelevic G. M., Kocjan T., Markou A., Hormone replacement therapy in postmenopausal women. Minerva Endocrinologica 2005 30 1 27 36 2-s2.0-23644441316
10. Gray S., Breast cancer and hormone-replacement therapy: the Million Women Study. The Lancet 2003 362 9392 1332 1332 2-s2.0-4944254101
11. Orija I. B., Mehta A., Hormone replacement therapy: current controversies. Clinical Endocrinology 2003 59 5, article 657 2-s2.0-0242320249
12. Lacey J. V. Jr., Mink P. J., Lubin J. H., Sherman M. E., Troisi R., Hartge P., Schatzkin A., Schairer C., Menopausal hormone replacement therapy and risk of ovarian cancer. The Journal of the American Medical Association 2002 288 3 334 341 10.1001/jama.288.3.334 2-s2.0-0037125454
13. Rossouw J. E., Anderson G. L., Prentice R. L., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. The Journal of the American Medical Association 2002 288 3 321 333 2-s2.0-33747069106
14. Lee J. K., Kim K. W., Choi J. Y., Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. Journal of the Korean Association of Oral and Maxillofacial Surgeons 2013 39 9 13
15. Riggs B. L., Hodgson S. F., O'Fallon M. W., Chao E. Y. S., Wahner H. W., Muhs J. M., Cedel S. L., Melton L. J. III, Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. The New England Journal of Medicine 1990 322 12 802 809 10.1056/NEJM199003223221203 2-s2.0-0025374223
16. In brief: cancer risk with salmon calcitonin. Medical Letter on Drugs and Therapeutics 2013 55 1414 29
17. Verhaar H. J., Lems W. F., PTH-analogs: comparable or different? Archives of Gerontology and Geriatrics 2009 49 2 130 132 10.1016/j.archger.2008.11.004 2-s2.0-67649687522
18. Qi W., Yan Y.-B., Lei W., Wu Z., Zhang Y., Liu D., Shi L., Cao P., Liu N., Prevention of disuse osteoporosis in rats by Cordyceps sinensis extract. Osteoporosis International 2012 23 9 2347 2357 10.1007/s00198-011-1842-4 2-s2.0-84867101910
19. Zhao X., Wu Z. X., Zhang Y., Yan Y., He Q., Cao P., Lei W., Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats. Journal of Ethnopharmacology 2011 137 3 1083 1088 10.1016/j.jep.2011.07.017 2-s2.0-80054903977
20. Zhang R., Liu Z. G., Li C., Hu S. J., Liu L., Wang J. P., Mei Q. B., Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats. Bone 2009 45 3 553 559 10.1016/j.bone.2008.08.127 2-s2.0-67949120224
21. Hosseinzadeh H., Modaghegh M. H., Saffari Z., Crocus sativus L. (saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle. Evidence-Based Complementary and Alternative Medicine 2009 6 3 343 350 10.1093/ecam/nem125 2-s2.0-68849096206
22. Rios J. L., Recio M. C., Ginger R. M., An update review of saffron and its active constituents. Phytotherapy Research 1996 10 189 193
23. Zargari A., Medicinal Plants 1990 Tehran University Press
24. Hosseinzadeh H., Nassiri-Asl M., Avicenna's (Ibn Sina) the canon of medicine and saffron (Crocus sativus): a review. Phytotherapy Research 2013 27 4 475 483 10.1002/ptr.4784 2-s2.0-84876290925
25. Rezaee R., Hosseinzadeh H., Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iranian Journal of Basic Medical Sciences 2013 16 1 12 26 2-s2.0-84872832475
26. Alavizadeh S. H., Hosseinzadeh H., Bioactivity assessment and toxicity of crocin: a comprehensive review. Food and Chemical Toxicology 2014 64 65 80 10.1016/j.fct.2013.11.016
27. Abdullaev F. I., Espinosa-Aguirre J. J., Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detection and Prevention 2004 28 6 426 432 10.1016/j.cdp.2004.09.002 2-s2.0-9644268896
28. Wang Y., Han T., Zhu Y., Zheng C., Ming Q., Rahman K., Qin L., Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. Journal of Natural Medicines 2010 64 1 24 30 10.1007/s11418-009-0360-6 2-s2.0-77949490080
29. Hosseinzadeh H., Noraei N. B., Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytotherapy Research 2009 23 6 768 774 10.1002/ptr.2597 2-s2.0-67149128716
30. Hong Y. J., Yang K. S., Anti-inflammatory activities of crocetin derivatives from processed Gardenia jasminoides. Archives of Pharmacal Research 2013 36 8 933 940 10.1007/s12272-013-0128-0 2-s2.0-84881316446
31. Nam K. N., Park Y.-M., Jung H.-J., Lee J. Y., Min B. D., Park S., Jung W., Cho K., Park J., Kang I., Hong J., Lee E. H., Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. European Journal of Pharmacology 2010 648 1-3 110 116 10.1016/j.ejphar.2010.09.003 2-s2.0-77957755920
32. Hosseinzadeh H., Sadeghnia H. R., Ghaeni F. A., Motamedshariaty V. S., Mohajeri S. A., Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytotherapy Research 2012 26 3 381 386 10.1002/ptr.3566 2-s2.0-84858005351
33. Razavi M., Hosseinzadeh H., Abnous K., Motamedshariaty V. S., Imenshahidi M., Crocin restores hypotensive effect of subchronic administration of diazinon in rats. Iranian Journal of Basic Medical Sciences 2013 16 1 64 72 2-s2.0-84872852890
34. Mehdizadeh R., Parizadeh M., Khooei A., Mehri S., Hosseinzadeh H., Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats. Iranian Journal of Basic Medical Sciences 2013 16 1 56 63 2-s2.0-84872867286
35. Hosseinzadeh H., Talebzadeh F., Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia 2005 76 7-8 722 724 10.1016/j.fitote.2005.07.008 2-s2.0-27444447828
36. Li X., Huang T., Jiang G., Gong W., Qian H., Zou C., Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis. Toxicology Letters 2013 221 3 197 204 10.1016/j.toxlet.2013.06.233 2-s2.0-84881225755
37. Hemshekhar M., Santhosh M. S., Sunitha K., Thushara R. M., Kemparaju K., Rangappa K. S., Girish K. S., A dietary colorant crocin mitigates arthritis and associated secondary complications by modulating cartilage deteriorating enzymes, inflammatory mediators and antioxidant status. Biochimie 2012 94 12 2723 2733 10.1016/j.biochi.2012.08.013 2-s2.0-84868215221
38. Assimopoulou A. N., Sinakos Z., Papageorgiou V. P., Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytotherapy Research 2005 19 11 997 1000 10.1002/ptr.1749 2-s2.0-29244478599
39. El-Beshbishy H. A., Hassan M. H., Aly H. A. A., Doghish A. S., Alghaithy A. A. A., Crocin "saffron" protects against beryllium chloride toxicity in rats through diminution of oxidative stress and enhancing gene expression of antioxidant enzymes. Ecotoxicology and Environmental Safety 2012 83 47 54 10.1016/j.ecoenv.2012.06.003 2-s2.0-84864112551
40. Asdaq S. M., Inamdar M. N., Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats. Applied Biochemistry and Biotechnology 2010 162 2 358 372 10.1007/s12010-009-8740-7 2-s2.0-77952881985
41. Manolagas S. C., From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocrine Reviews 2010 31 3 266 300 10.1210/er.2009-0024 2-s2.0-75149129597
42. Li M., Shen Y., Wronski T. J., Time course of femoral neck osteopenia in ovariectomized rats. Bone 1997 20 1 55 61 10.1016/S8756-3282(96)00317-1 2-s2.0-0031032420
43. Shen Y., Li Y.-Q., Li S.-P., Ma L., Ding L.-J., Ji H., Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins. Journal of Natural Medicines 2010 64 3 336 345 10.1007/s11418-010-0416-7 2-s2.0-77953621304
44. Turner C. H., Burr D. B., Basic biomechanical measurements of bone: a tutorial. Bone 1993 14 4 595 608 10.1016/8756-3282(93)90081-K 2-s2.0-0027175806
45. Kono Y., Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of Biochemistry and Biophysics 1978 186 1 189 195 10.1016/0003-9861(78)90479-4 2-s2.0-0017804313
46. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 10.1016/0003-2697(79)90738-3 2-s2.0-0018384650
47. Schreiweis M. A., Butler J. P., Kulkarni N. H., Knierman M. D., Higgs R. E., Halladay D. L., Onyia J. E., Hale J. E., A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers. Journal of Cellular Biochemistry 2007 101 2 466 476 10.1002/jcb.21196 2-s2.0-34247889970
48. Wright L. E., Frye J. B., Timmermann B. N., Funk J. L., Protection of trabecular bone in ovariectomized rats by turmeric (Curcuma longa L.) Is dependent on extract composition. Journal of Agricultural and Food Chemistry 2010 58 17 9498 9504 10.1021/jf101873f 2-s2.0-77956236963
49. Yamaguchi K., Shinohara C., Kojima S., Sodeoka M., Tsuji T., (2E,6R)-8-hydroxy-2,6-dimethyl-2-octenoic acid, a novel Anti-osteoporotic monoterpene, isolated from Cistanche salsa. Bioscience, Biotechnology and Biochemistry 1999 63 4 731 735 10.1271/bbb.63.731 2-s2.0-0033112758
50. Hwang Y., Jeong I., Ahn K. J., Chung H. Y., The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women. Journal of Bone and Mineral Metabolism 2009 27 5 584 590 10.1007/s00774-009-0093-3 2-s2.0-68949163531
51. Zhang D., Zhang J., Fong C., Yao X., Yang M., Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2/M arrest and apoptosis. Biochimie 2012 94 12 2514 2522 10.1016/j.biochi.2012.06.033 2-s2.0-84868195814
52. Wronski T. J., Dann L. M., Scott K. S., Crooke L. R., Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology 1989 125 2 810 816 10.1210/endo-125-2-810 2-s2.0-0024307588
53. Turner R. T., Vandersteenhoven J. J., Bell N. H., The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats. Journal of Bone and Mineral Research 1987 2 2 115 122 2-s2.0-0023320347
54. Liu X. Q., Cui L., Wu T., Study of bone histomorphometric changes at regular intervals in OVX rats. Chinese Journal of Osteoporosis 2005 11 427 429
55. McElroy J. F., Wade G. N., Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats. Physiology & Behavior 1987 39 3 361 365 10.1016/0031-9384(87)90235-6 2-s2.0-0023121558
56. Dang Z. C., Van Bezooijen R. L., Karperien M., Papapoulos S. E., Löwik C. W. G. M., Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. Journal of Bone and Mineral Research 2002 17 3 394 405 10.1359/jbmr.2002.17.3.394 2-s2.0-0036182265
57. Park J. A., Ha S. K., Kang T. H., Oh M. S., Cho M. H., Lee S. Y., Park J., Kim S. Y., Protective effect of apigenin on ovariectomy-induced bone loss in rats. Life Sciences 2008 82 25-26 1217 1223 10.1016/j.lfs.2008.03.021 2-s2.0-44649178200
58. Cummings S. R., Bates D., Black D. M., Clinical use of bone densitometry: scientific review. Journal of the American Medical Association 2002 288 15 1889 1897 10.1001/jama.288.15.1889 2-s2.0-0037120864
59. Gibson L. J., The mechanical behaviour of cancellous bone. Journal of Biomechanics 1985 18 5 317 328 10.1016/0021-9290(85)90287-8 2-s2.0-0021880663
60. Rice J. C., Cowin S. C., Bowman J. A., On the dependence of the elasticity and strength of cancellous bone on apparent density. Journal of Biomechanics 1988 21 2 155 168 10.1016/0021-9290(88)90008-5 2-s2.0-0023868463
61. Keaveny T. M., Morgan E. F., Niebur G. L., Yeh O. C., Biomechanics of trabecular bone. Annual Review of Biomedical Engineering 2001 3 307 333 10.1146/annurev.bioeng.3.1.307 2-s2.0-0034802787
62. Allende-Vigo M. Z., The use of biochemical markers of bone turnover in osteoporosis. Puerto Rico Health Sciences Journal 2007 26 2 91 95 2-s2.0-38449111407